{"id":{"repo_id":"rowan","oai_identifier":"oai:rdw.rowan.edu:etd-2512"},"canonical_url":"https://search.dev.ndltd.org/etd/rowan/oai:rdw.rowan.edu:etd-2512","repository":{"repo_id":"rowan","name":"Rowan University","base_url":"https://rdw.rowan.edu/do/oai/"},"display":{"title":"The effects of Naltrexone on severe self-injurious behavior in inpatient adults with developmental disabilities","abstract":"<p>The purpose of this thesis was to explore the probability that Naltrexone can reduce self-injurious behavior, specifically the frequency, as measured by total number of incidents, and severity, measured by total number of self-inflicted injuries. Naltrexone is a pure opiate antagonist, which internally alters the reinforcement contingencies that maintain self-injurious behavior. One of the factors that contribute to the maintenance of self-injurious behavior is the endorphins that are naturally released when the body experiences pain. These endorphins can cause a pleasant, euphoric feeling, which internally reinforces self-inflicted painful experiences.</p> <p>Available records were reviewed for 7 male inpatient adults with developmental disabilities to ascertain the effects of Naltrexone on their severe self-injurious behavior and rates of self-inflicted injuries. Data was be presented in terms of behavior frequencies for baseline phase, lasting six months, and treatment phase, also six months in duration. A t-test was used to compare baseline and treatment phases.</p> <p>The data presented in this study allows this researcher to reject the null hypothesis (of no effect) and accept the alternate hypothesis that there would be a difference in self-injurious behavior, as measured by injury rates and frequencies of behavior, between the baseline and treatment phases. Although the behavior frequency did not decrease significantly the severity of SIB did decrease significantly as evidenced by the reduction in injuries.</p>","abstract_html":"&lt;p&gt;The purpose of this thesis was to explore the probability that Naltrexone can reduce self-injurious behavior, specifically the frequency, as measured by total number of incidents, and severity, measured by total number of self-inflicted injuries. Naltrexone is a pure opiate antagonist, which internally alters the reinforcement contingencies that maintain self-injurious behavior. One of the factors that contribute to the maintenance of self-injurious behavior is the endorphins that are naturally released when the body experiences pain. These endorphins can cause a pleasant, euphoric feeling, which internally reinforces self-inflicted painful experiences.&lt;/p&gt; &lt;p&gt;Available records were reviewed for 7 male inpatient adults with developmental disabilities to ascertain the effects of Naltrexone on their severe self-injurious behavior and rates of self-inflicted injuries. Data was be presented in terms of behavior frequencies for baseline phase, lasting six months, and treatment phase, also six months in duration. A t-test was used to compare baseline and treatment phases.&lt;/p&gt; &lt;p&gt;The data presented in this study allows this researcher to reject the null hypothesis (of no effect) and accept the alternate hypothesis that there would be a difference in self-injurious behavior, as measured by injury rates and frequencies of behavior, between the baseline and treatment phases. Although the behavior frequency did not decrease significantly the severity of SIB did decrease significantly as evidenced by the reduction in injuries.&lt;/p&gt;","abstract_has_math":false,"creators":["Simmerman, Kimberly L."],"institution":null,"degree_name":"M.A. in School Psychology","degree_level":"Thesis","degree_discipline":"Educational Services and Leadership","degree_department":null,"school":null,"contributors":["Klanderman, John","Dihoff, Roberta"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2002,"date_issued":"2002-05-01T07:00:00Z","date_published":"2002-05-01T07:00:00Z","updated_at":"2026-07-24T04:14:32Z","subjects":["Developmentally disabled; Self-destructive behavior","Educational Psychology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://rdw.rowan.edu/etd/1512","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Klanderman, John","Dihoff, Roberta"]},{"key":"dc:creator","label":"Author","values":["Simmerman, Kimberly L."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2016-05-19T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Educational Services and Leadership"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["M.A. in School Psychology"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Developmentally disabled; Self-destructive behavior","Educational Psychology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://rdw.rowan.edu/etd/1512"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p>The purpose of this thesis was to explore the probability that Naltrexone can reduce self-injurious behavior, specifically the frequency, as measured by total number of incidents, and severity, measured by total number of self-inflicted injuries. Naltrexone is a pure opiate antagonist, which internally alters the reinforcement contingencies that maintain self-injurious behavior. One of the factors that contribute to the maintenance of self-injurious behavior is the endorphins that are naturally released when the body experiences pain. These endorphins can cause a pleasant, euphoric feeling, which internally reinforces self-inflicted painful experiences.</p> <p>Available records were reviewed for 7 male inpatient adults with developmental disabilities to ascertain the effects of Naltrexone on their severe self-injurious behavior and rates of self-inflicted injuries. Data was be presented in terms of behavior frequencies for baseline phase, lasting six months, and treatment phase, also six months in duration. A t-test was used to compare baseline and treatment phases.</p> <p>The data presented in this study allows this researcher to reject the null hypothesis (of no effect) and accept the alternate hypothesis that there would be a difference in self-injurious behavior, as measured by injury rates and frequencies of behavior, between the baseline and treatment phases. Although the behavior frequency did not decrease significantly the severity of SIB did decrease significantly as evidenced by the reduction in injuries.</p>"]},{"key":"dc:title","label":"Title","values":["The effects of Naltrexone on severe self-injurious behavior in inpatient adults with developmental disabilities"]}]}],"canonical_facts":{"dc:contributor":["Klanderman, John","Dihoff, Roberta"],"dc:creator":["Simmerman, Kimberly L."],"dc:date.available":["2016-05-19T07:00:00Z"],"dc:description.abstract":["<p>The purpose of this thesis was to explore the probability that Naltrexone can reduce self-injurious behavior, specifically the frequency, as measured by total number of incidents, and severity, measured by total number of self-inflicted injuries. Naltrexone is a pure opiate antagonist, which internally alters the reinforcement contingencies that maintain self-injurious behavior. One of the factors that contribute to the maintenance of self-injurious behavior is the endorphins that are naturally released when the body experiences pain. These endorphins can cause a pleasant, euphoric feeling, which internally reinforces self-inflicted painful experiences.</p> <p>Available records were reviewed for 7 male inpatient adults with developmental disabilities to ascertain the effects of Naltrexone on their severe self-injurious behavior and rates of self-inflicted injuries. Data was be presented in terms of behavior frequencies for baseline phase, lasting six months, and treatment phase, also six months in duration. A t-test was used to compare baseline and treatment phases.</p> <p>The data presented in this study allows this researcher to reject the null hypothesis (of no effect) and accept the alternate hypothesis that there would be a difference in self-injurious behavior, as measured by injury rates and frequencies of behavior, between the baseline and treatment phases. Although the behavior frequency did not decrease significantly the severity of SIB did decrease significantly as evidenced by the reduction in injuries.</p>"],"dc:identifier":["https://rdw.rowan.edu/etd/1512"],"dc:subject":["Developmentally disabled; Self-destructive behavior","Educational Psychology"],"dc:title":["The effects of Naltrexone on severe self-injurious behavior in inpatient adults with developmental disabilities"],"thesis:degree_discipline":["Educational Services and Leadership"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["M.A. in School Psychology"]},"updated_at":"2026-07-24T04:14:32Z"}